Managed care joint ventures are ranked as a medium factor when it comes to the introduction of new products. This is because when two managed care organizations link, they establish sticker rules that limit new products from being introduced into the health system (Arcangelo &Peterson, 2005). This is because the products will undergo rigorous scrutiny in terms of their benefits to the patients, how long they have been in operation in other regions or if their tests were successful and most important their prices. If they do not fit in any of the required categories, then they are disregarded.
Case management Case management involves nurses and other social workers looking into specific matters such as maternity cases and claim management. Their roles entail ensuring that they coordinate insurance services as well as various claims that people may have. Through this, they are able to analyze the areas where most complaints are filed. “Access to such information means that restrictions will be made in the areas that have the most complaints and this will mean certain products will be reduced and the patients cannot have access to them (McCarthy & Schafermeyer, 2004).
” Case management fro this reason can be ranked as a low factor. Conclusion Managed care has enabled people to access health care at affordable prices as well as ensuring that the medical practitioners follow the legal and professional standards. Despite the good they are trying to enhance, managed care organizations need to lighten the restrictions that inhibit the entry of new products which are geared towards improving the lives of the people. Pharmaceutical companies need to be supported by managed care organizations so that they can continue with the provision of better medical facilities as well as research work.
These actions will increase the roles they play and public trust in these institutions will increase. References Arcangelo, V. P. &Peterson, A. M. (2005). Pharmacotherapeutics for advanced practice: a practical approach, 2nd Ed. Lippincott Williams & Wilkins, 2005, pp. 898-902 Frick, D. K. (June 1999). Cross product subsidization in the health insurance market with managed care: A Model and issues. Atlantic Economic Journal, John Hopkins University, U. S. A. Vol. 27, No. 2 McCarthy, R. L. & Schafermeyer, K. W. (2004). Introduction to health care delivery: a primer for pharmacists, 3rd Ed. Jones & Bartlett Publishers, 2004, pp. 119-120